logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Endothelial Progenitor Cells A New Real Hope 1st Edition Carmela Rita Balistreri Auth

  • SKU: BELL-5883522
Endothelial Progenitor Cells A New Real Hope 1st Edition Carmela Rita Balistreri Auth
$ 31.00 $ 45.00 (-31%)

0.0

0 reviews

Endothelial Progenitor Cells A New Real Hope 1st Edition Carmela Rita Balistreri Auth instant download after payment.

Publisher: Springer International Publishing
File Extension: PDF
File size: 2.75 MB
Pages: 99
Author: Carmela Rita Balistreri (auth.)
ISBN: 9783319551067, 9783319551074, 331955106X, 3319551078
Language: English
Year: 2017
Edition: 1

Product desciption

Endothelial Progenitor Cells A New Real Hope 1st Edition Carmela Rita Balistreri Auth by Carmela Rita Balistreri (auth.) 9783319551067, 9783319551074, 331955106X, 3319551078 instant download after payment.

This book explores the role of endothelial progenitor cells (EPCs) in the context of regenerative medicine (RegMed). In particular, it reveals the value of RegMed as a new TM branch intended to improve the health and quality of life, by restoring, maintaining or enhancing tissue and functions of organs.

The book is divided into three chapters, the first of which describes the relevance of translational medicine (TM) as a new research approach to counteract the imposing challengeof age-related diseases. Of the diverse RegMed approaches, particular attention is paid to stem/progenitor cell-based therapies, their benefits and shortcomings, as well as to the description of types of stem and progenitor cells considered for regenerative cell therapies, such as EPCs as emerging candidates for RegMed applications.

In turn, the second chapter outlines the clinical relevance of EPCs as both potential predictors, diagnostic and prognostic biomarkers of age-related diseases and therapeutic agents,discussing their advantages, disadvantages, and conflicting data.

Chapter three proposes a potential roadmap for revising the findings and creating a clearer picture of valid data, which can provide support for various important aspects, i.e.isolating and characterizing EPCs by establishing standardized criteria for EPC research, identifying appropriate sub-populations for cell therapy, timing, dosing, priming of cells,and defining delivery modes for different applications.

The book concludes with an overview of innovative strategies that could improve the efficacy of cell therapy at all levels, including cell priming, bio-nanotechnology, and tissue engineering.

Related Products